Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$1.13 +1.8%	$1.38	$1.08 ▼ $21.49	$5.41M	-2.96	1.47 million shs	188,942 shs
PTHL Pheton	$0.67 +2.6%	$14.94	$0.60 ▼ $32.00	$4.28M	N/A	4.03 million shs	511,309 shs
RSLSD ReShape Lifesciences		$0.00	$2.91 ▼ $82.80	$1.90M	2.03	1,362 shs	6,500 shs
SINT Sintx Technologies	$3.05 -1.0%	$2.98	$1.71 ▼ $8.60	$8.49M	0.65	66,394 shs	48,828 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	+1.80%	-8.87%	-20.42%	-42.05%	-90.72%
PTHL Pheton	+2.63%	-25.25%	-96.76%	-87.35%	+66,709,900.00%
RSLSD ReShape Lifesciences	0.00%	0.00%	0.00%	0.00%	0.00%
SINT Sintx Technologies	-0.97%	+13.81%	+9.71%	-3.48%	-27.55%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMIX Autonomix Medical	2.808 of 5 stars	3.5	2.0	0.0	0.0	2.4	1.7	1.3
PTHL Pheton	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	3.0674 of 5 stars	3.5	4.0	0.0	0.0	3.9	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	3.00	Buy	$16.50	1,360.18% Upside
PTHL Pheton	0.00	N/A	N/A	N/A
RSLSD ReShape Lifesciences	0.00	N/A	N/A	N/A
SINT Sintx Technologies	3.00	Buy	$28.00	818.03% Upside

Current Analyst Ratings Breakdown

Latest RSLSD, SINT, PTHL, and AMIX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/30/2025	SINT Sintx Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$30.00 ➝ $28.00

(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$3.29 per share	N/A
PTHL Pheton	$450K	9.75	N/A	N/A	$0.94 per share	0.71
RSLSD ReShape Lifesciences	$610K	0.00	N/A	0.08	$341.84 per share	0.00
SINT Sintx Technologies	$2.89M	2.91	N/A	N/A	$2.90 per share	1.05

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$11.41M	-$7.47	N/A	N/A	N/A	N/A	-173.47%	-133.22%	N/A
PTHL Pheton	-$660K	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences	-$81.15M	N/A	0.00	N/A	N/A	-668.58%	-163.22%	-52.10%	N/A
SINT Sintx Technologies	-$11.02M	-$50.56	N/A	∞	N/A	-483.85%	-203.66%	-104.76%	N/A

Latest RSLSD, SINT, PTHL, and AMIX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	SINT Sintx Technologies	-$0.79	-$0.91	-$0.12	-$0.91	N/A	N/A
8/13/2025	Q1 2026	AMIX Autonomix Medical	N/A	-$1.07	N/A	-$1.07	N/A	N/A
5/29/2025	Q4 2025	AMIX Autonomix Medical	N/A	-$0.74	N/A	-$0.74	N/A	N/A
5/15/2025	Q1 2025	SINT Sintx Technologies	-$0.71	-$1.29	-$0.58	-$1.29	$0.73 million	$0.37 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
PTHL Pheton	N/A	N/A	N/A	N/A	N/A
RSLSD ReShape Lifesciences	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	5.63	5.63
PTHL Pheton	N/A	12.39	12.17
RSLSD ReShape Lifesciences	0.05	1.17	1.07
SINT Sintx Technologies	N/A	3.44	3.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
PTHL Pheton	N/A
RSLSD ReShape Lifesciences	N/A
SINT Sintx Technologies	18.38%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	32.40%
PTHL Pheton	N/A
RSLSD ReShape Lifesciences	N/A
SINT Sintx Technologies	4.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	1	4.88 million	3.30 million	N/A
PTHL Pheton	11	6.58 million	N/A	N/A
RSLSD ReShape Lifesciences	50	354,000	N/A	Not Optionable
SINT Sintx Technologies	40	2.76 million	2.64 million	Not Optionable

RSLSD, SINT, PTHL, and AMIX Headlines

Recent News About These Companies

Sintx Technologies (SINT) Expected to Announce Quarterly Earnings on Tuesday

August 10, 2025 | americanbankingnews.com

Sintx Technologies (NASDAQ:SINT) versus Bluejay Diagnostics (NASDAQ:BJDX) Financial Contrast

August 6, 2025 | americanbankingnews.com

Sintx Technologies (NASDAQ:SINT) Stock Price Down 0.7% - Here's Why

August 6, 2025 | americanbankingnews.com

Short Interest in Sintx Technologies, Inc. (NASDAQ:SINT) Expands By 217.8%

August 6, 2025 | americanbankingnews.com

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

August 4, 2025 | globenewswire.com

SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices

July 22, 2025 | taiwannews.com.twT

Sintx Technologies, Inc. (SINT) - Yahoo Finance

June 27, 2025 | finance.yahoo.com

SINTX Technologies Acquires Surgical Business Assets Of SiNAPTIC Holdings - Nasdaq

June 26, 2025 | nasdaq.com

SINTX Technologies stock jumps on deal to acquire SiNAPTIC surgical assets

June 24, 2025 | msn.com

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

June 24, 2025 | globenewswire.com

Mark Lewis Anderson Acquires 10,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) Stock

June 24, 2025 | insidertrades.com

SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors

June 13, 2025 | tmcnet.com

Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary

May 23, 2025 | msn.com

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025 | globenewswire.com

SiNtx Technologies Inc.

May 19, 2025 | marketwatch.com

SiNtx Technologies Inc.

May 19, 2025 | marketwatch.com

SINTX Technologies, Inc.: SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 16, 2025 | finanznachrichten.de

Mark Lewis Anderson Purchases 5,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) Stock

May 15, 2025 | insidertrades.com

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025 | globenewswire.com

Sintx Technologies, Inc. (NASDAQ:SINT) Insider Gregg R. Honigblum Buys 10,000 Shares

May 1, 2025 | insidertrades.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RSLSD, SINT, PTHL, and AMIX Company Descriptions

Autonomix Medical NASDAQ:AMIX

$1.13 +0.02 (+1.80%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$1.12 -0.01 (-0.88%)

As of 08/14/2025 04:27 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Pheton NASDAQ:PTHL

$0.67 +0.02 (+2.63%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$0.66 -0.01 (-1.66%)

As of 08/14/2025 07:58 PM Eastern

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

ReShape Lifesciences OTCMKTS:RSLSD

ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

Sintx Technologies NASDAQ:SINT

$3.05 -0.03 (-0.97%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$2.92 -0.13 (-4.10%)

As of 08/14/2025 06:26 PM Eastern

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time